Vontobel Holding’s ADMA Biologics ADMA Stock Holding History

Vontobel Holding’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,643	Closed	-$273K	–	1097
2024 Q3	$273K	Buy	13,643 +888	+7%	+$13.8K	﹤0.01%	940
2024 Q2	$143K	Buy	+12,755	New	+$107K	﹤0.01%	1010

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vontobel Holding's ADMA Position: Q4 2024 in Review

Vontobel Holding sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 13,643 shares — an estimated $273K sold.

Vontobel Holding first reported a position in ADMA in Q2 2024 and held it in 2 quarters. The position peaked at $273K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

Vontobel Holding reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
Vontobel Holding sold 13,643 ADMA Biologics shares in Q4 2024, an estimated $273K.
Vontobel Holding first reported a position in ADMA Biologics in Q2 2024 and held it in 2 quarters.
Vontobel Holding's ADMA Biologics position peaked at $273K in Q3 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Vontobel Holding's 13F filing for Q4 2024, filed 30 Jan 2025.